Zevra Therapeutics (ZVRA) Net Margin (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Net Margin of 104.61% for Q1 2026, up 193.84% on a QoQ basis from 35.6% in Q4 2025, and up 11980.0% year-over-year from N/an in Q1 2025.
Zevra Therapeutics (ZVRA) Net Margin (2019 - 2026) Analysis & Trends
Zevra Therapeutics' Net Margin history runs 8 years deep, the most recent figure standing at 104.61% for Q1 2026.
- Quarterly Net Margin rose 11980.0% year-over-year to 104.61% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 101.54% (up 32863.0% YoY) and the FY2025 annual result came in at 78.17%, up 52502.0% from the prior year.
- Net Margin was 104.61% for Q1 2026 at Zevra Therapeutics, up from 35.6% in the prior quarter.
- Across five years, Net Margin topped out at 288.66% in Q2 2025 and bottomed at 1920.29% in Q2 2022.
- A 5-year average of 327.7% and a median of 269.01% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin plunged 183106 bps — and 2023, when it jumped 188991 bps.
- Zevra Therapeutics' Net Margin stood at 446.14% in 2022, then surged by 65 bps to 153.96% in 2023, then slumped by 93 bps to 297.53% in 2024, then jumped by 112 bps to 35.6% in 2025, then soared by 194 bps to 104.61% in 2026.
- Business Quant data shows ZVRA's Net Margin at 104.61% in Q1 2026, 35.6% in Q4 2025, and 2.09% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 104.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.61% |
| Dec 31, 2025 | 35.60% |
| Sep 30, 2025 | -2.09% |
| Jun 30, 2025 | 288.66% |
| Mar 31, 2025 | -15.19% |
| Dec 31, 2024 | -297.53% |
| Sep 30, 2024 | -899.19% |
| Jun 30, 2024 | -452.84% |
| Mar 31, 2024 | -485.31% |
| Dec 31, 2023 | -153.96% |
| Sep 30, 2023 | -358.10% |
| Jun 30, 2023 | -30.38% |
| Mar 31, 2023 | -370.50% |
| Dec 31, 2022 | -446.14% |
| Sep 30, 2022 | -240.49% |
| Jun 30, 2022 | -1,920.29% |
| Dec 31, 2021 | -104.69% |
| Sep 30, 2021 | -89.52% |
| Jun 30, 2021 | -89.23% |
| Mar 31, 2021 | -393.99% |